Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Dec 16;17(1):211.
doi: 10.1186/s12890-017-0559-3.

Legionella pneumonia due to non-Legionella pneumophila serogroup 1: usefulness of the six-point scoring system

Affiliations

Legionella pneumonia due to non-Legionella pneumophila serogroup 1: usefulness of the six-point scoring system

Akihiro Ito et al. BMC Pulm Med. .

Abstract

Background: Because of a limited number of reports, we aimed to investigate the clinical characteristics of patients with Legionella pneumonia due to non-Legionella pneumophila serogroup 1 and the diagnostic usefulness of the six-point scoring system for such patients compared with patients with pneumonia caused by L. pneumophila serogroup 1.

Methods: We retrospectively analysed patients diagnosed with Legionella pneumonia due to non-L. pneumophila serogroup 1 between March 2001 and June 2016. We examined the clinical characteristics, including symptoms, laboratory findings, radiologic findings, pneumonia severity, initial treatment and prognosis. We also calculated scores using the six-point scoring system in these patients. Furthermore, we compared the clinical characteristics and six-point scores between non-L. pneumophila serogroup 1 patients and L. pneumophila serogroup 1 patients among hospitalized community-acquired pneumonia patients enrolled prospectively between October 2010 and July 2016.

Results: Eleven patients had pneumonia due to non-L. pneumophila serogroup 1; their median age was 66 years and 8 patients (72.7%) were male. The most common pathogen was L. pneumophila serogroup 3 (6/11), followed by L. pneumophila serogroup 9 (3/11), L. pneumophila serogroup 6 (1/11) and L. longbeachae (1/11). Non-specific symptoms, such as fever and cough, were common. Six patients (54.5%) had liver enzyme elevation, but no patient developed hyponatraemia at <130 mEq/L. Nine patients (81.8%) showed lobar pneumonia and 7 patients (63.6%) manifested with consolidation and ground-glass opacity. Patients with mild to moderate severity comprised 10 (90.9%) by CURB-65 and 5 (45.5%) by the Pneumonia Severity Index. Of all patients, 4 were admitted to the intensive care unit and 3 died despite appropriate empiric therapy. The clinical characteristics were not significantly different between non-L. pneumophila serogroup 1 patients and L. pneumophila serogroup 1 patients (n = 23). At a cut-off value of ≥ 2 points, the sensitivity of the six-point scoring system was 54.5% (6/11) for non-L. pneumophila serogroup 1 patients and 95.7% (22/23) for L. pneumophila serogroup 1 patients.

Conclusions: Cases of non-L. pneumophila serogroup 1 pneumonia varied in severity from mild to severe and the clinical characteristics were often non-specific. The six-point scoring system was not useful in predicting such Legionella pneumonia cases.

Keywords: Community-acquired pneumonia; Diagnostic scoring system; Legionella pneumonia; Legionella pneumophila serogroup 1.

PubMed Disclaimer

Conflict of interest statement

Ethics approval and consent to participate

This study was approved by the institutional review board of Kurashiki Central Hospital (approval number 2364). All patients gave their informed consent to participate in this study.

Consent for publication

Consent for publication was not required because all patient data were anonymised.

Competing interests

Tadashi Ishida has received honoraria from Pfizer, Japan, Inc. The other authors have no conflicts of interest to declare.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Similar articles

Cited by

References

    1. Ishida T, Tachibana H, Ito A, Tanaka M, Tokioka F, Furuta K, et al. Clinical characteristics of severe community-acquired pneumonia among younger patients: an analysis of 18 years at a community hospital. J Infect Chemother. 2014;20:471–476. doi: 10.1016/j.jiac.2014.04.005. - DOI - PubMed
    1. Amemura-Maekawa J, Kura F, Helbig JH, Chang B, Kaneko A, Watanabe Y, et al. Characterization of Legionella pneumophila isolates from patients in Japan according to serogroups, monoclonal antibody subgroups and sequence types. J Med Microbiol. 2010;59:653–659. doi: 10.1099/jmm.0.017509-0. - DOI - PubMed
    1. Helbig JH, Bernander S, Castellani P, Etienne J, Gaia V, Lauwers S, et al. Pan-European study on culture-proven legionnaires’ disease: distribution of Legionella pneumophila serogroups and monoclonal subgroups. Eur J Clin Microbiol Infect Dis. 2002;21:710–716. doi: 10.1007/s10096-002-0820-3. - DOI - PubMed
    1. Chen CY, Chen KY, Hsueh PR, Yang PC. Severe community-acquired pneumonia due to Legionella pneumophila serogroup 6. J Formos Med Assoc. 2006;105:256–262. doi: 10.1016/S0929-6646(09)60316-8. - DOI - PubMed
    1. Lück PC, Schneider T, Wagner J, Walther I, Reif U, Weber S, et al. Community-acquired legionnaires’ disease caused by Legionella pneumophila serogroup 10 linked to the private home. J Med Microbiol. 2008;57:240–243. doi: 10.1099/jmm.0.47382-0. - DOI - PubMed

Substances